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VasopressinSfmbt2-hostedmiR-466a-3p and its close relatives are often among themost signiﬁcantly up-regulated or down-
regulatedmiRNAs in responses to numerous deleterious environmental stimuli. The exact roles of these miRNAs
in cellular stress responses, however, are not clear. Here we showed that many Sfmbt2-hosted miRNAs were
highly hypertonic stress responsive in vitro and in vivo. In renal medulla, water deprivation induced alterations
in the expression of miR-466(a/b/c/e/p)-3p in a pattern similar to that of miR-200b-3p, a known regulator of
osmoresponsive transcription factor Nfat5. Remarkably, exposure of mIMCD3 cells to an arginine vasopressin
analog time-dependently down-regulated the expression of miR-466(a/b/c/e/p)-3p and miR-200b-3p, which
provides a novel regulatory mechanism for these osmoresponsive miRNAs. In cultured mIMCD3 cells we further
demonstrated that miR-466a-3p and miR-466g were capable of targeting Nfat5 by interacting with its 3′UTR. In
transgenic mice overexpressing miR-466a-3p, signiﬁcant down-regulation of Nfat5 and many other
osmoregulation-related genes was observed in both the renal cortex and medulla. Moreover, sustained
transgenic over-expression of miR-466a-3p was found to be associated with polydipsia, polyuria and disturbed
ion homeostasis and kidney morphology. Since the mature sequence of miR-466a-3p is completely equivalent
to that of miR-466e-3p and that the seed sequence of miR-466a-3p is completely equivalent to that
of miR-297(a/b/c)-3p, miR-466d-3p, miR-467g and miR-669d-3p, and that miR-466a-3p differs from
miR-466(b/c/p)-3p only in a 5′ nucleotide, we propose that miR-466a-3p and many of its close relatives are
important epigenetic regulators of renal Nfat5 signaling, osmoregulation and urine concentration in mice.
© 2013 The Authors. Published by Elsevier B.V.Open access under CC BY-NC-SA license.1. Introduction
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ed signiﬁcantly to hypertonicity-induced induction of osmoregulatory
transcription factor nuclear factor of activated T cell-5/osmotic response
element binding protein/tonicity responsive element binding protein
(Nfat5/OREBP/TonEBP) [4,8,16,19]. These ﬁndings ﬁrmly established
the essential roles of miR-200b-3p and miR-717 in renal osmoregulation
and homeostasis [5,14,15,44]. However, the roles of many other
tonicity-responsive miRNAs, in particular those that appeared to
be regulated in an opposite direction as compared with that of
miR-200b-3p and miR-717 in vitro (i.e., up-regulated rather than
down-regulated following the 2-h hypertonicity exposure), were
largely uncharacterized and remained to be further investigated.
Interestingly, among the 21 miRNAs signiﬁcantly up-regulated by 2
folds or more following the 2-h hypertonicity exposure in mIMCD3
cells, 9 miRNAs (namely miR-466(a/b/c/e)-3p, miR-466g, miR-669c,
miR-467b* and miR-467a*/d*) were derived from a single miRNA
cluster hosted by the 10th intron of the Polycomb group gene Sex
combs on the midleg with four MBT domains-2 (Sfmbt2) on mouse
chromosome 2 (hence also called Chromosome 2 miRNA cluster,
C2MC) [26,49]. Recent studies have shown that miRNA members of
C2MC might play important roles in cell proliferation and apoptosis
[10,11,47,49], cell fate decision [9,32,37,39], and immune response
[27]. Moreover, C2MC is believed to be recently expanded through
retrotransposon-mediated gene duplication [26,49]. C2MC miRNAs
thus bear high degrees of sequence similarity, especially within
the subclusters (miR-297s, miR-466s, miR-467s and miR-669s).
Furthermore, in spite of the fact that in cultured cells the 9 C2MC
miRNAs appeared to respond to high NaCl-hypertonicity in an opposite
manner as compared with that of miR-200b-3p and miR-717 in vitro,
bioinformatic analyses indicated that many C2MC miRNAs potentially
might target Nfat5 as well (Table S1 & Fig. S3 in the Appendix). In this
current study, we performed a series of in vitro and in vivo studies to
investigate the roles of miR-466a-3p and miR-466g in the post-
transcriptional regulation of Nfat5, urine concentration, renal osmoregu-
lation and osmoadaptation. We found that miR-466a-3p, miR-466g and
their close relatives might be evolutionally selected as epigenetic
osmoregulators that are partly responsible for the robust osmoregulatory
systems present in the rodents.
2. Materials and methods
2.1. Plasmids
A DNA fragment containing mouse miR-466a mini-gene (442 bp)
was ampliﬁed from mouse genomic DNA prepared from mouse inner
medullary collecting duct epithelial-3 (mIMCD3) cells through PCR
ampliﬁcation, using the primers listed in Table S2 in the Appendix.
The EcoRI-PstI digested DNA fragment was sub-cloned into pIRES2-
EGFP (Clontech, Mountain View, CA, USA) to generate pmiR-466a.
Similarly, a mouse miR-466g miRNA gene (411 bp) was PCR-ampliﬁed
using genomic DNA prepared frommIMCD3 cells using primers as listed
in Table S2. The resultant DNA fragment was subcloned into pFlag-CMV2
(Sigma-Aldrich China, Inc., Shanghai, China), using the HindIII and XbaI
sites. The insertions of the resultant plasmids pmiR-466a and pmiR-
466gwere conﬁrmedbyDNAsequencing. PlasmidpmiR-574was created
as described previously [20].
Luciferase reporter pNfat5-3′UTR-luc containing the full length
Nfat5-3′UTR was actually the previously-constructed pOREBP-3′UTR-1
as described [16]. For the construction of miR-466a-3p-speciﬁc
miRNA recognition element (MRE)-luciferase reporter plasmids, DNA
fragments containing the wild-type (WT) and a mutated miR-466a-3p
MRE (the middle one of the three predicted MREs on mouse Nfat5-3′
UTR, Fig. 2A) were ampliﬁed frommIMCD3 cDNA through PCR ampliﬁ-
cation with the LA Taq DNA Polymerase (TaKaRa, Dalian, China) and
appropriate primers as listed on Table S2 in the Appendix. The FseI
and XbaI digested PCR fragments were sub-cloned into the pGL3-control vector (Promega, Madison, WI, USA), using the FseI and XbaI
sites immediately downstream the stop codon of the luciferase cDNA,
generating the WT reporter pWT-MRE-luc and the mutated reporter
pMT-MRE-luc respectively.
2.2. Preparation of transgenic mice overexpressing miR-466a-5p/3p
XbaI-digested pmiR-466a was end-ﬁlled by Klenow polymerase
reactions. The linearizedDNAwas further digestedwith EcoRI to release
the miR-466a minigene. Meanwhile, plasmid pCAG-IPuro (Invitrogen,
Carlsbad, CA, USA) was digested with ClaI and end-ﬁlled and further
digested with EcoRI. The DNA fragment released from pmiR-466a was
subsequently subcloned into the pCAG-IPuro such that the expression
of miR-466a expression was under the control of a chicken β-actin
promoter. The β-actin promoter-miR-466a DNA fragment was released
by restriction enzymes SalI and SwaI and used for pronuclear microinjec-
tionwith FBVmouse eggs by standard protocols. For the determination of
the presence of transgene in the transgenic mice, genomic DNA was
extracted from mouse tails samples and PCR was performed with two
pairs of primers (common primer: 5′-TCAGGGAGAGTTATCACCCA-3′;
genomic-control primer: 5′-ATCCAAAAGGCAAGCGTT-3′; transgene-
speciﬁc: 5′-GGCTCGTATGTTGTGTGGAA-3′, Sangon, Shanghai, China).
The founder FBV mice were bred with WT FBV mice and the F2 mice
were used for all other analyses.
2.3. Cell transfection, treatments and 3′UTR-luciferase reporter assays
mIMCD3 cells were purchased from ATCC (CRL-2123, Manassas,
VA, USA) and cultured as instructed. Transfections withmiRNA over-
expressing plasmids, miR-466a-5p/3p mimics or their controls
(miR-466a-5p target sequence 5′-UAUGUGUGUGUACAUGUACAUA-
3′, miR-466a-3p target sequence 5′-UAUACAUACACGCACACAUAAGA-
3′, miR-ctrl target sequence 5′-UUCUCCGAACGUGUCACGUTT-3′,
Genepharma Co. Ltd., Shanghai, China) or a chemically synthesized
antisense miR-466a-3p inhibitor (anti-miR-466a-3p) (SS03A1,
Invitrogen Trading (Shanghai), Co. Ltd., Shanghai, China) and its
control (anti-miR-ctrl) were performed using Lipofectamine
(Invitrogen, Carlsbad, CA, USA) as instructed. For desmopressin
(1-desamino-8-D-arginine vasopressin, ddAVP, H20065069, Hainan
Zhonghe Phamarceutical Co. Ltd., Haikou, China) treatment, 80%
conﬂuence cells were exposed to ddAVP at a ﬁnal concentration of
1.2 nM and cell samples were collected at speciﬁed time points
for miRNA analyses. For 3′UTR-luciferase reporter assays, cells were
co-transfected with one of the three luciferase reporters (pNfat5-3′
UTR-luc-1, pWT-MRE-luc and pMT-MRE-luc), the miR-466a-5p/3p
overexpressing plasmid (pmiR-466a or pmiR-466g) or the control
pIRES2-EGFP, and pSV40-β-galactosidase at the ratio of 4:3:1 for 24 h.
Cells were subsequently harvested for the luciferase activity assays
and β-galactosidase activity assays as described previously [16].
2.4. Quantitative real-time PCR (qPCR) analyses ofmiRNAs andmRNAs and
Western blot analyses of proteins
The expression of mRNAs andmiRNAswere analyzed by qPCR using
primers listed on Table S3 and Table S4 as described previously
[16]. Western blots were performed according to standard protocols
using antibodies listed on Table S5 in the Appendix. The detection
was achieved using the Immobilon Western Chemiluminescent HRP
Substrate kit (Millipore, MA, USA). Western blot images were captured
by Biosense SC8108 Gel Documentation System with GeneScope
V1.73 software (Shanghai BioTech, Shanghai, China). Gel images were
imported into Photoshop for orientation and cropping. The digital
density values were acquired by Image-Pro Plus software (Media
Cybernetics, Shanghai, China) and analyzed by Prism 5.0 (Graphpad,
La Jolla, CA, USA).
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Animal experiments were conducted according to protocols and
guidelines that were approved by the Xiamen University Institutional
Animal Care and Use Committee. WT and miR-466a transgenic FVB
mice were normally maintained in a 12-h light/dark cycle under
controlled temperature (20–22 °C) and humidity (50–65%) in the
Xiamen University Laboratory Animal Center. Only 8–10 weeks old
male mice were used in our studies and mice were allowed free access
to standard mouse chow and water unless indicated otherwise. For
untreated animals,micewere trained inmetabolic cages (urine collection
cage, DXL-S, Suzhou Fengshi Laboratory Animal Equipment Co., Ltd,
Suzhou, China; water consumpation cage, TSE LabMaster, TSE Systems,
Inc., Chesterﬁeld, MO, USA) with free access to standard mouse chow
and water for 24 h, then the measurement of water consumption and
urine output/collection was performed over a 24 h period. For water
deprivation, mice were initially put into metabolic cages individually for
1 day with free access to standardmouse chow andwater. Water bottles
were then removed for a period of 24 h. For ddAVP treatment, similarly-
trainedmice were intraperitoneally injectedwith ddAVP at the dosage of
4 μg/kg. For water deprived and ddAVP-treated mice and controls, urine
samples were collected by bladder message or the metabolic cages,
serum samples were collected by sinus puncture. Themice were eventu-
ally sacriﬁced by cervical dislocation and renal cortex and medulla
samples were dissected for protein, mRNA and miRNA analyses.
2.6. Serum and urine analysis
Serum levels of sodium, potassium, calcium, magnesium, chloride,
urea, creatinine and albumin were measured with the Hitachi-747
Autoanalyzer (Boehringer-Mannheim, Mannheim, Germany). Urinary
levels of sodium, potassium, calcium, magnesium, chloride, urea, and
creatinine were assayed with the Synchron CX5 Analyzer (Beckman
Instruments, Inc., Fullerton, CA, USA). Urine and serum osmolarity
were measured by the vapor pressure method, using the Vapro vapor
pressure osmometer (Wescor Inc., Logan, UT, USA). Alternatively,
urine osmolarity was also determined with a freezing-point depression
osmometer (STY-1, Tianda, Tianjin, China). Serum arginine vasopressin
(AVP) concentrations were determined with an ELISA kit (R&D, MN,
USA) according to manufacturer's instructions.
2.7. Histological analyses of parafﬁn-embedded kidney sections
Dissected kidneyswere postﬁxed overnight in 4% paraformaldehyde
at 4 °C following the removal of the capsules. The ﬁxed tissues were
parafﬁn embedded and sectioned at 5-μm thickness. Hemotoxylin and
eosin staining was performed according to standard protocols.
2.8. Bioinformatic and statistical analyses
The nomenclature and sequences of precursor and mature miRNAs
were based on miRBase 20 (microrna.sanger.ac.uk), unless otherwise
indicated. miRNA target predictions were performed with the miRanda
(www.microrna.org) or the Targetscan (www.targetscan.org) algorithm.
Data were the means ± SEM. One-way ANOVA with Bonferonni's
post-test was used for multiple comparisons and the Student's t-test
(two-tailed) for pair-wise comparisons.
3. Results
3.1. Many C2MC miRNAs are tonicity responsive in vitro and in vivo
We performed multiple sequence alignment for 30 -5p and 20 -3p
C2MC miRNA sequences. The results showed that both the -3p and
-5p sequences showed high degrees of similarity (Fig. 1A & S1 in the
Appendix). In fact, 20 C2MC -3p miRNAs not only share a high degreeof sequence similarity, many of them (e.g., miR-297(a/b/c)-3p, miR-
467g, miR-466(a/d/e)-3p and miR-669d-3p) actually share a common
seed sequence of AUACAU across the miR-297 s, miR-466 s, miR-
467 s and miR-669 s subfamilies (Fig. 1A). Remarkably, miR-466a-3p
is completely equivalent to miR-466e-3p in terms of the mature se-
quences. miR-466a-3p also differs from miR-466(b/c/p)-3p only in an
extra 5′-end U respectively and from miR-466d-3p only in the last
three nucleotides on the 3′-end. These observations suggest that these
C2MC -3p miRNAs might have common targets and similar functions.
We demonstrated previously by miRNA array analyses that many
C2MC -3p miRNAs were among the most signiﬁcantly up-regulated
miRNAs in mIMCD3 cells following the high NaCl exposure (Fig. S1 in
the Appendix) [16]. To verify this result, we performed miRNA qPCR
analyses with mIMCD3 cells following similar tonicity treatments (i.e.,
550 mOsmol/kg H2O high NaCl hypertonicity versus 300 mOsmol/kg
H2O isotonicity). With primer sets speciﬁc for miR-466(a/b/c/e/p)-3p
and miR-466g (Table S4 in the Appendix), we conﬁrmed that miR-
466(a/b/c/e/p)-3p were signiﬁcantly up-regulated by 2-h, which
peaked at 4-h and fall subsequently and returned to the normal levels
by 8-h after the hypertonicity exposure (Fig. 1B). A similar but less
signiﬁcant trend was observed for miR-466g and this trend differed
from that of miR-200b-3p and miR-717 in an opposite manner. In
the renal medulla of FVB mice that were water deprived, however,
signiﬁcant down-regulations in medullary miR-466(a/b/c/e/p)-3p
were observed at 8-h, which sustained at least to 16-h and returned to
the normal levels by 24-h (Fig. 1C). miR-466(a/b/c/e/p)-3p and miR-
200b-3p thus appeared to be physiologically regulated in the same
direction in vivo, despite that in vitro they appeared to respond to high
NaCl hypertonicity in an opposite direction in the initial stages.
Interestingly, exposure of mIMCD3 cells to 1.2 nM ddAVP time-
dependently down-regulated the expression of miR-200b-3p and miR-
466(a/b/c/e/p)-3p (Fig. 1D), suggesting that AVP probably is necessary
for suppressing the expression of miR-466(a/b/c/e/p)-3p. This result
largely explains the opposite trends between high NaCl-induced up-
regulation of miR-466(a/b/c/e/p)-3p in vitro in mIMCD3 cells and water
deprivation-induced down-regulation of miR-466(a/b/c/e/p)-3p in vivo,
as the brain-derived endogenous AVP appeared to be necessary for
the suppression of miR-466(a/b/c/e/p)-3p and it was missing from
the in vitro cell culture system. Together these results suggest that
C2MC -3p miRNAs likely play important roles in osmoregulation and
osmoadaptation.
3.2. Post-transcriptional regulation of Nfat5 bymiR-466a-3p andmiR-466g
but not miR-466a-5p
As stated above, many C2MC miRNAs might have common targets
and functions. Indeed, our bioinformatics analyses by either the miRan-
da algorithm (Table S1 and Fig. S4 & S5A in the Appendix) or the
Targetscan algorithm (Fig. S3 in the Appendix) suggested that a large
number of C2MC -3pmiRNAsmight be able to target the osmoregulato-
ry transcription factor Nfat5 post-transcriptionally. For instance, 3
potential MREs were predicted for miR-466a-3p (Fig. 2A) and another
3 were predicted for miR-466a-5p (Fig. S4) on Nfat5-3′-untranslated
region (3′UTR) by the miRanda algorithm. For miR-466g, which is
actually a -3p sequence, 8 putative MREs were predicted (Fig. S5A). In
mIMCD3 cells transfected with a chemically synthesized miR-466a-3p
mimic, the mRNA and protein expression of Nfat5were signiﬁcantly re-
duced (Fig. 2C&D). On the contrary,Nfat5 not onlywas not reduced, in-
stead it was slightly increased in cells transfected with a miR-466a-5p
mimic (Fig. 2C). Moreover, a similar reduction in the mRNA and protein
expression of Nfat5 was also observed in cells transfected with pmiR-
466a (in these cells miR-466a-3p was increased by approximately 2.5
folds). Meanwhile, cotransfection studies with luciferase reporters
containing a WT and mutant MRE of Nfat5-3′UTR respectively with
either the miR-466a-3p overexpressing pmiR-466a or its control
pIRES2-EGFP conﬁrmed that miR-466a-3p targeted Nfat5 through
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Fig. 1. C2MC miRNAs are tonicity-responsive and might be regulated by anti-diuretic hormone AVP. A, Multiple sequence alignment of 20 mature C2MC−3p miRNAs. B, Time
course expression of miR-466(a/b/c/e/p)-3p and miR-466g in cultured mIMCD3 cells under isotonic condition or high NaCl hypertonicity (550 mOsmol/kg H2O). miRNA was
determined by real-time RT-PCR usingmiRNA-speciﬁc primers (n ≥ 3). The values for miR-200b-3p andmiR-717 were adopted fromHuang et al. [16]. C, Time course expression
of miR-466(a/b/c/e/p)-3p and miR-200b-3p in the renal medulla of WT FVB mice following water deprivation (n = 3). U6 RNA-calibrated values for the 0-h was used for the
normalization of corresponding values at 2-, 4-, 6- and 8-h. D, Time course expression of miR-466(a/b/c/e/p)-3p and miR-200b-3p in cultured mIMCD3 cells exposed to 1.2
nM ddAVP (n = 3). U6 RNA-calibrated values for the 0-h were used for the normalization of corresponding values at 1-, 2-, 3- and 4-h.
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performed for miR-466g, the results of which suggest that miR-466g is
also capable of targeting Nfat5 (Fig. S5). To further investigate whether
miR-466a-3p is of functional signiﬁcance at its endogenous level in
mIMCD3 cells, we utilized a chemically-synthesized miR-466a-3p inhibi-
tor (anti-sense RNA for miR-466a-3p) to speciﬁcally knockdown miR-
466a-3p. Additionally, we also transfected cells with pWT-MRE-luc,
which contains a putative miR-466a-3p MRE site and serves as a
“miRNA sponge” to compete with the full-length endogenous Nfat5
mRNA formiR-466a-3p bindingwhen overexpressed [12,13]. Our results
indicated that knockdown of miR-466a-3p or overexpression of themiR-
466a-3p sponge both substantially increased the mRNA or protein
expression of Nfat5 (Fig. 2C & D), although the increase in Nfat5 protein
in anti-miR-466a-3p-treated cells was not statistically signiﬁcant
(Fig. 2D), which is likely due to a relatively low n number (n = 3). To-
gether these results thus ﬁrmly establish the functional signiﬁcance of
endogenous miR-466a-3p and indicate that miR-466a-3p and miR-466g
might play important roles in posttranscriptional regulation of Nfat5.
3.3. Transgenic overexpression of miR-466a-3p is associated with
signiﬁcant down-regulation of renal Nfat5 and other
osmoregulation-related genes
Multiple transgenic founder FBVmice carrying the β-actin promoter-
miR-466a mini-transgene were obtained following the conventional
pronuclear microinjections as described in the Materials and methodssection. Among these, two transgenic founders (Tg1 and Tg2) were
selected for further crosses between a transgenic mouse and a WT
mouse to produce heterozygotic FBV mice (Tg1+/− and Tg2+/−) for all
subsequent characterizations and experiments. Both Tg1+/− and
Tg2+/− mice appeared to live and breed normally, although the body
weight of Tg1+/−mice was slightly reduced (Fig. S7 in the Appendix),
as compared with that of the WT mice. The expression of miR-466a-3p
in Tg1+/− mice was increased by approximately 20-fold (Fig. 3A) in
the renal cortex and 15.5-fold in the medulla (Fig. 3B), whereas the
expression of miR-466a-5p was virtually negligible. In the renal cortex
and medulla of Tg2+/− mice, the expression of miR-466a-3p was
increased by approximately 167-fold and 97-fold respectively, with
much smaller increases in the expression of miR-466a-5p. The difference
in miR-466a-3p expression between the Tg1+/− and Tg2+/− mice is
likely resulted from the differences in the copy number of the transgene
as well as the site of transgene integration, both of which are common
to transgenesis. These results suggest that miR-466a-3p is signiﬁcantly
increased in renal cortex and medulla in both lines of transgenic mice.
Additionally, signiﬁcant transgenic expression of miR-466a-3p was also
found in the heart (~ 59-fold of induction) and the brain (~4.4-fold
induction) tissues but not in the liver, lung, intestine and testis in
8–10 weeks old male Tg1+/−mice (Fig. S6A in the Appendix), whereas
the transgenic expression of miR-466a-3p in 8–10 weeks old male
Tg2+/− mice appeared to be very signiﬁcantly increased in all tissues
examined (Fig. S6B in the Appendix), which included the heart, liver,
lung, brain, intestine and testis.
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Fig. 2.miR-466a-3p but not miR-466a-5p targets Nfat5. mIMCD3 cells were transfected with miR-466a-3p mimic or pmiR-466a. Twenty-four hours after the transfection, cells were
harvested for mRNA or protein analyses. Data are expressed as the mean ± SEM, n ≥ 3. *, p b 0.05; **, p b 0.01; ***, p b 0.001, compared with miR-ctrl, pIRES2-EGFP, anti-miR-
ctrl or pFlag-CMV2 transfected cells respectively. A, Three putative miR-466a-3p-speciﬁc MREs on mouse Nfat5-3′UTR. The numbering of 3′UTR nucleotides was based on miRanda
(www.microrna.com). B, miR-466a-3p targets Nfat5 through the interaction with an MRE on Nfat5 3′UTR. C, Effects of overexpression of miR-466a-5p/3p or inhibition of miR-466a-3p
on the mRNA expression of Nfat5 in mIMCD3 cells. For overexpression, cells were transfected with miR-466a-5p/3p or miR-466a-5p/3p-overexpressing pmiR-466a. For inhibition of
miR-466a-3p, cells were transfected with chemically synthesized antisense siRNA (anti-miR-466a-3p or its control anti-miR-ctrl) or a “miR466a-3p sponge” pWT-MRE-luc. D, Effects
of transfection with miR-466a-3p mimics or inhibition of miR-466a-3p on the protein expression of Nfat5 in mIMCD3 cells.
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cortical Nfat5 mRNA was found to be signiﬁcantly down-regulated as
comparedwith that of theWTmice (Fig. 3C). Moreover, the renal cortical
mRNA levels of a few other major osmoregulation-related genes that
were known to be under the transcriptional control of Nfat5, which
included aldose reductase (Ar), sodium–myoinositol co-transporter
(Smit), aquaporins (Aqp1, Aqp2, and Aqp3), urea transporters (UtA1,
UtA2 and UtA3) and serum serum/glucocorticoid-induced kinase-1
(Sgk1), were all found to be signiﬁcantly down-regulated (Fig. 3C).
Similarly, Nfat5, Aqp2, Aqp3, UtA1, UtA2, UtA3 and Sgk1 mRNAs were
found to be signiﬁcantly down-regulated in the renal medulla of
Tg1+/− mice, except that for Ar and Smit and Aqp1 (Fig. 3D). Western
blot analyses conﬁrmed signiﬁcant down-regulation of Nfat5, Ar, Aqp2and UtA1 proteins in renal medulla and Ar and Aqp2 in renal cortex of
Tg1+/−mice (Fig. 3E). Moreover, consistent with the much higher levels
of transgenic expression of miR-466a-3p in renal cortex and medulla of
the Tg2+/− mice, the mRNA and protein expression of Nfat5, Aqp2
in the renal cortex and medulla in the Tg2+/− mice was in general
lower than that of the age and gender-matched Tg1+/−mice, whereas
not much difference was observed for UtA1 and Sgk1 between the
Tg1+/− and Tg2+/− mice (Fig. 3C & D). Western blot analyses also
indicated strong suppression of Nfat5, Ar, Aqp2 and Sgk1 protein in
the renal cortex and medulla of the Tg2+/− mice (Fig. 3F). In the
heart and brain tissues of the Tg2+/− mice, Nfat5 mRNA was shown
to be signiﬁcantly down-regulated, although this did not appear to
be proportional to the increase in miR-466a-3p (Fig. S6C in the
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Fig. 3. The creation of transgenic FVB mice overexpressing miR-466a-5p/3p. Data are expressed as the mean ± SEM, n N = 3. *, p b 0.05; **, p b 0.01; ***, p b 0.001, compared with the
WTmice. A, Renal cortical expression ofmiR-466a-5p/3p in 8–10 weeks oldmaleWT, Tg1+/− and Tg2+/−mice as analyzed by qPCR. B, Renalmedullary expression of miR-466a-5p/3p in
8–10 weeks old male WT, Tg1+/− and Tg2+/−mice as analyzed by qPCR. C, mRNA expression of osmoregulation-related genes in renal cortex of 8–10 weeks old male WT, Tg1+/− and
Tg2+/−mice as analyzed by qPCR. D, mRNA expression of osmoregulation-related genes in renal medulla of 8–10 weeks old male WT, Tg1+/− and Tg2+/−mice as analyzed by qPCR. E,
Protein expression of Nfat5, Ar, Aqp2, and UtA1 in renal cortex andmedulla of 8–10 weeks oldmaleWT and Tg1+/−mice as analyzed byWestern blots. F, A typicalWestern blot showing
protein expression of Nfat5, Ar, Aqp2 and Sgk1 in renal cortex and medulla of 8–10 weeks old male WT and Tg2+/−mice as analyzed byWestern blots.
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genic overexpression of miR-466a-3p in both lines of transgenics
effectively suppressed the expression of a group of osmoregulation-
related genes, which included Nfat5, aquaporins, urea transporters
and Sgk1, in both the renal cortex and medulla.3.4. Sustained transgenic overexpression of miR-466a-3p causes polyuria,
polydipsia and disturbed ion homeostasis in mice
Weperformedmetabolic cage experiments to evaluate the effects of
forced renal overexpression of miR-466a-3p. As shown in Fig. 4A, the
103Y. Luo et al. / Biochimica et Biophysica Acta 1839 (2014) 97–106daily water intake and urine output for Tg1+/− mice were increased
by approximately 80% and 291% respectively. Meanwhile, the urine
osmolarity for either the untreated or ddAVP-treated Tg1+/− mice
was 21% lower than that of the control mice (Fig. 4B). Similar polyuric
and polydipsic phenotypes were observed for the Tg2+/−mice except
that the urine output and urine osmolarity for Tg2+/− mice are not
signiﬁcantly different from that of the Tg1+/−mice, the reason for this
is not clear (Fig. 4A & B). Urine analyses indicated that most solutes in
urine collected from Tg1+/−mice were diluted but the daily excretion
was largely unchanged, except that formagnesium (Table 1). Moreover,
ELISA analyses indicated that the serum level of AVP was not decreased
but instead increased in Tg1+/−mice (Table 2), suggesting that despite
the signiﬁcantly up-regulated level of miR-466a-3p in the brain
(Fig. S6A), the secretion of endogenous AVP was not affected. Of note
is that normal or raised AVP is normally associated with the inability
to concentrate urine in nephrogenic diabetes insipidus human patients
[1,30,46]. In addition, the systolic and diatolic and themean blood pres-
sure (Fig. S7D) were not affected despite signiﬁcantly up-regulated
miR-466a-3p (Fig. S6A & 6B in the Appendix) and down-regulated
Nfat5 in the heart of the Tg2+/−mice (Fig. S6C in the Appendix). How-
ever, serum osmolarity and serum solutes including sodium, calcium,A
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A, Water intake and urine output 8–10 weeks oldmaleWT, Tg1+/−, Tg2+/−mice (n = 4–6).M
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water ad libitum. Urine sampleswere collected 2 h after intraperitoneal injection of ddAVP (4 μg
protein (n = 3). D, A typical morphology image of renal medulla tissues for 8–10 weeks old mchloride, creatinine, urea and albumin in Tg1+/− mice were slightly
increased, whereas potassium and magnesium were not (Table 2).
This probably indicates a modest impairment in ion homeostasis. In
renal medulla, water deprivation failed to induce the up-regulation
of Nfat5 protein (Fig. 4C), conﬁrming a compromised Nfat5 signaling.
Hemotoxylin and eosin staining showed disturbed morphology
(e.g., dilated collecting tubules and disorganized tubules and vasa
recta) of the renal medulla of in both Tg1+/− and Tg2+/−mice as com-
pared with that of theWTmice (Fig. 4D), while relatively less apparent
or no differences were observed for the renal cortex (Fig. S8 in the
Appendix). Together these in vivo results indicate that miR-466a-3p is
an important ribo-regulator in the control of osmoregulation-related
genes, urine concentration and ion homeostasis in mice.
4. Discussion
miRNAs are emerging as major regulators of kidney development,
function and renal diseases [5,15,22,35,44]. C2MC is one of the largest
miRNA clusters in mice and rats [26]. Additionally, a number of miRNAs
homologous to C2MC miRNAs were also found in chicken and insects
[20,21]. As stated above, mouse C2MC is a recently acquired miRNAB
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/kg of bodyweight). C, Effects ofwater deprivation on renalmedullary expression of Nfat5
ale WT and Tg1+/− and Tg2+/−mice as determined by hematoxylin and eosin staining.
Table 1
Urine analyses. Urine samples were collected from the WT and Tg1+/− mice. Analyses
were performed as described in the Materials and methods section.
Solute Concentration/24 h
excretion
WT
(n = 6)
Tg1+/−
(n = 6)
p
Sodium mM 125.00 ± 5.00 90.00 ± 0.00 b 0.001
mmol 0.075 ± 0.003 0.104 ± 0.032 NS
Potassium mM 255.65 ± 26.85 196.63 ± 25.97 b 0.05
mmol 0.153 ± 0.025 0.226 ± 0.069 NS
Calcium mM 2.55 ± 0.45 1.97 ± 0.05 NS
mmol 0.0015 ± 0.0003 0.0023 ± 0.0007 NS
Magnesium mM 4.10 ± 0.70 8.56 ± 0.05 b 0.001
mmol 0.0025 ± 0.0004 0.0098 ± 0.0030 b 0.05
Chloride mM 160.00 ± 0.00 133.33 ± 25.00 NS
mmol 0.096 ± 0.016 0.153 ± 0.047 NS
Creatinine μM 4210 ± 180 3233 ± 150 b 0.01
μmol 2.53 ± 0.42 3.72 ± 1.13 NS
Urea mM 815.6 ± 41.5 567.1 ± 9.6 b 0.001
mmol 0.49 ± 0.08 0.65 ± 0.20 NS
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[26,49], which contains at least 71 closely-related miRNA genes
[48]. C2MC miRNAs are highly enriched in the placenta, the kidney,
the heart, the mouse stem cells and some other tissues or cells
[16,39,48,49]. In mice, many C2MC miRNAs were identiﬁed to be the
major components in the dynamic regulatory network during embry-
onic development [39], skeletal and cardiac muscle differentiation or
function [9,36], angiogenesis [3] and lung development [37]. Studies
have also shown that many C2MC miRNAs or their relatives were
often among the most signiﬁcantly-altered miRNAs in responses to
multiple types of cellular stresses, which included nutrition deprivation
[11], hyperglycemia [3,38], hypertonic stress [16], oxidative stress [43],
xenobiotic stress [41], aging [48], cigarette smoke [17,18], septic shock
[40] and virus infection [7,28]. Although there were studies showing
that a few C2MC miRNAs might act as important ribo-regulators in the
control of cell fate decision, cell proliferation, immune responses, cell
cycle and apoptosis [9,11,27,32,37,39,49], the exact roles of many
more C2MC miRNAs in cellular stress responses and other biological
processes were unknown and remained to be further explored.
In our current study, we ﬁrst conﬁrmed thatmiR-466a-3p andmany
of its C2MC close relatives were hypertonic stress responsive, although
paradoxically high NaCl hypertonicity exposure in cultured mIMCD3
cells did not appear to induce alterations in the expression of miR-
466(a/b/c/e/p)-3p in a similar way as that in the renal medulla of
water deprived mice in vivo. Importantly, we showed that ddAVP
exposure acutely down-regulated miR-466(a/b/c/e/p)-3p and miR-
200b-3p, which suggests that the hypertonicity-inducible endogenous
AVP is capable of regulating the renal expression of many C2MC and
miR-200 family miRNAs negatively. To the best of our knowledge, this
is the ﬁrst demonstration linking the brain hypothalamus-derived
anti-diuretic hormone AVP with renal miRNA expression, which also
provides a novel regulatory mechanism for the stress-responsive miR-
200 family and the C2MC miRNAs.Table 2
Serum analyses. Serum samples were collected from the WT and Tg1+/−mice. Analyses
were performed as described in the Materials and methods section.
WT
(n = 8)
Tg1+/−
(n = 10)
P
Osmolarity (mOsmol/kg H2O) 304 ± 1 332 ± 3 b0.001
Sodium (mM) 140.00 ± 1.31 151.5 ± 2.50 b0.01
Potassium (mM) 8.87 ± 0.50 8.95 ± 0.69 NS
Calcium (mM) 1.99 ± 0.01 2.21 ± 0.01 b0.001
Magnesium (mM) 0.91 ± 0.04 1.04 ± 0.09 NS
Chloride (mM) 106.00 ± 0.40 118.00 ± 0.00 b0.001
Creatinine (μM) 40 ± 1.00 45 ± 0.00 b0.001
Urea (mM) 7.79 ± 0.08 9.52 ± 0.09 b0.001
Albumin (g/L) 27.50 ± 0.25 30.7 ± 0.50 b0.001
AVP (ng/L) 67.8 ± 7.4 77.9 ± 8.0 b0.05In cultured mIMCD3 cells, we further showed that miR-466(a/e)-3p
and miR-466g were capable of regulating Nfat5 post-transcriptionally,
through interacting with the corresponding MREs on the 3′UTR. Since
Nfat5 is a central regulator of cellular osmoregulation and an essential
regulator of renal development and function [8,16,24,31], we created
lines of transgenic mice to demonstrate the regulation of Nfat5 by
miR-466a-3p in vivo and to explore the effects of overexpression of
miR-466a-3p on kidney structure and functions. We found that trans-
genic renal overexpression of miR-466a-3p led to a signiﬁcant down-
regulation of osmoregulation-associated genes including Nfat5, Ar,
Smit, Aqp2, UtA1, UtA2, UtA3 and Sgk1, which ﬁrmly established the
regulatory role of miR-466a-3p in the posttranscriptional regulation of
renalNfat5. Long term overexpression ofmiR-466a-3p in the transgenic
mice, however, was shown to cause abnormalities in renal structure and
function. miR-466a-3p-overexpressing transgenic mice developed
modest polydipsia, polyuria, suggesting defects in renal osmoregulation
and urine concentration. The down-regulation of osmoregulation-
related genes and the polydipsia and polyuria in mice overexpressing
miR-466a-3p was also consistent with a renal defect in Nfat5 signaling
[24]. In comparison with that of Nfat5 knockouts [31], however, the
phenotypes in the miR-466a-3p-transgenic mice are in general less
severe. Considering a signal transduction axis of AVP-miR-466a-3p/
miR-200b-3p-Nfat5-Aqp2/UtA1/UtA3, on the other hand, it is plausible
that the elevated plasma hypertonicity inwater deprivedmice probably
induces AVP to suppress miR-466a-3p andmiR-200b-3p to up-regulate
the expression of Nfat5 and water channels and urea transporters,
which should contribute signiﬁcantly to the enhanced water retention
and urine concentration.
Consistent with that in the Nfat5 knockouts [2] or the dominant-
negative Nfat5 transgenic mice [24], the levels of plasma/serum sodium
and urea (blood urea nitrogen) or the serum osmolarity in miR-466a-
3p-transgenic Tg1+/− mice were signiﬁcantly elevated, suggesting a
defective ion homeostasis caused by miR-466a-3p-induced down-
regulation of Nfat5. In line with this, recent studies have identiﬁed
Sgk1 as a direct transcriptional target of Nfat5 in rats [6] and in human
CD4+ T cells [23]. Sgk1 is a critical regulator of epithelial transport
and ion homeostasis, which activates a wide variety of ion channels
(e.g., ENaC, SCN5A, TRPV4–6, ROMK, Kv1.3 and Orai/STIM) [25,29].
Sgk1-null mice displayed signiﬁcantly impaired ion homeostasis [45].
The disturbed ion homeostasis observed in our Tg1+/− mice thus can
largely be explained by a dys-regulated signaling cascade whereby
miR-466a-3p targets Nfat5 to repress Sgk1. The signaling defect in
the Nfat5-Sgk1 axis, meanwhile, also provides a mechanism for the
elevated plasma sodium and osmolality in the Nfat5 null mice or the
dominant negative Nfat5 transgenics. Since a miRNA is capable of
regulating multiple genes simultaneously, however, at this moment it
cannot be excluded that miR-466a-3p might also directly regulate
other genes involved in renal ion transport and homeostasis. Together
these results indicate that miR-466a-3p is an important regulator of
Nfat5, renal osmoregulation and osmoadaptation and ion homeostasis.
IsomiRs are miRNA variants that are normally different from a
particular canonical (the reference) miRNA in 1–2 nucleotides, which
are mainly generated by a shift of Drosha and Dicer in the cleavage sites
or by nucleotide additions or substitutions during miRNA biogenesis
[33,34]. C2MC -3p sequences as shown in Fig. 1A are the canonical
sequences embedded in their respective host miRNA genes. As men-
tioned above, miR-466a-3p is completely equivalent to miR-466e-3p
and it differs from miR-466(b/c/d/e/p) and more C2MC miRNAs only
in 1–2 nucleotides, suggesting that these miRNAs might be isomiRs
for each other [33,34]. For instance, by trimming off an extra 5′-end
U, the precursor for miR-466a-3p can easily be processed into miR-
466(b/c/p)-3p. It has been proposed that most isomiRs, particularly
those with the 3′-end variations or non-seed-based nucleotide substitu-
tions, are functionally overlapped or redundant [34]. Indeed, C2MC
miRNAs were often predicted to co-target the same MREs. Spruce et al.
suggested that miR-297b-3p, miR-466a-3p, miR-467-5p/3p and miR-
105Y. Luo et al. / Biochimica et Biophysica Acta 1839 (2014) 97–106669a-3p, which are highly enriched in both embryonic and extra-
embryonic cells, co-target cyclin-dependent kinase inhibitor 1C (Cdkn1c
or p57) and RAS p21 protein activator 2 (Rasa2) to participate in the
regulation of differentiation and early development [39]. Similarly, in
neural stem cells, high glucose/hyperglycemia caused signiﬁcantly
reduced expression of miR-200a-3p, miR-200b-3p, miR-466a-3p, miR-
466d-3p, which were demonstrated to co-target Doublecortin (Dcx)
and Platelet activating factor acetyl hydrolase, isoform 1b, subunit 1
(Pafah1b1), two genes involved in neurogenesis [38]. The later study is
of special interests also in that miR-200a-3p, miR-200b-3p, miR-466a-
3p and miR-466d-3p are very signiﬁcantly down-regulated together
under hyperglycemia, which lends further support to the notion that
under certain circumstances miR-466(a/b/c/e/p) and miR-200b-3p
can be regulated in the samedirection in vivo (Fig. 1C). Together these ob-
servations suggest thatmany C2MCmiRNAs probablywill be functionally
overlapped and that the results obtained for miR-466a-3p in this study
might at least be applicable to miR-466(a/b/c/d/e/p)-3p respectively.
In mice, the Sfmbt2 10th intron-hosted miRNA cluster potentially
encodes for more than 70 miRNAs [26,42,49]. In contrast, human
Sfmbt2 gene contains very few or no miRNA, although a few C2MC-
related miRNAs (e.g. hsa-miR-297 and hsa-miR-466) have been identi-
ﬁed in other parts of the human genome. It is conceivable that C2MC
miRNAs might thus be especially important for certain species-speciﬁc
functions. Noteworthy is that in human kidneys, the maximal urine
osmolarity is ~1200 mOsmol/kg, whereas in rodents, strong urine
concentrating mechanisms can concentrate urine up to an osmolarity
level of ~3000 mOsmol/kg, indicating a more robust osmoregulatory
system in the rodents. In this regard, the rodents and humans might
have evolved, at least in part, through evolving Nfat5 3′UTRs as well
as osmoregulatorymiRNAs, tomeet the need of differential renal osmo-
regulation and osmoadaptation. We demonstrated previously that the
difference between mouse and human Nfat5 3′UTRs contributes in
part to the differential Nfat5 signaling mediated by miR-200b-3p and
miR-717, two miRNAs that were found in both mouse and human
renal cells [16]. Our current studies advance this understanding by
suggesting that a large number of the more species-speciﬁc osmoregu-
latorymiRNAs, such asmiR-466a-3p and its close relatives, also contrib-
ute to the differential Nfat5 signaling and renal osmoregulation and
osmoadaptation between the humans and the rodents.
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